# Psychiatry Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Zelda Fitzgerald (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET004-SYN-TD
- Date: 1930-05-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Margot Ellery, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Desiree Langford, MD, Psychiatry
- Urgency: Within one week, on the same day as her one-week primary care visit

## Referral question

First episode of psychosis with marked manic and depressive symptoms in a 29-year-old dancer and writer, twelve days after discharge from a first psychiatric admission, on risperidone 2 mg at bedtime. Please review the provisional diagnosis and how to settle it, advise on a mood stabilizer to prevent another episode in a woman who could become pregnant, advise on the antipsychotic given a raised prolactin and absent periods, and enroll her in coordinated specialty care. **S**

## Questions for the consultant

1. What is the most likely diagnosis, and how should bipolar I disorder with psychotic features, schizoaffective disorder, and schizophrenia be told apart over time?
2. Which mood stabilizer should she take to prevent another episode, given that she could become pregnant?
3. Should she stay on risperidone, given her raised prolactin, absent periods, and fear of weight gain?
4. What monitoring do you advise for the mood stabilizer and the antipsychotic?
5. How should her eating, training, and return to dance be managed, and what will coordinated specialty care offer her?

## Pertinent history

For about three weeks before admission she slept two or three hours a night, talked rapidly, made grand plans, and trained in ballet for most of each day; she then heard a voice commenting on her dancing and believed she was being watched and tested by her instructors. The order in which these symptoms began is not yet clear. The admission lasted twelve days; the urine drug test was negative and medical causes were excluded, and risperidone was started. Since discharge she has been low, tearful, and tired (PHQ-9 11, item 9 scored 0); she has no thoughts of suicide or self-harm, a written safety plan, no firearm access, and the 988 Suicide & Crisis Lifeline in her phone. Her periods stopped about four months before admission, during six to eight hours of dance a day at a BMI of 18.7; SCOFF 1 of 5; no bingeing or purging. Pregnancy test negative in hospital. She uses condoms and does not want a pregnancy now. Results today: creatinine 0.72 mg/dL, eGFR 116, sodium 139, potassium 4.0 mmol/L, glucose 84 mg/dL, calcium 9.4 mg/dL, TSH 2.1 mIU/L, prolactin 62 ng/mL, A1c 5.0%, total cholesterol 168, LDL 90, HDL 64, triglycerides 70 mg/dL; hemoglobin 12.6 g/dL. Weight 50.8 kg, blood pressure 108/68. She fears weight gain will end her dancing. She decides who is told about her health. **S**

- Zelda Sayre was born on July 24, 1900, in Montgomery, Alabama, the youngest child of Alabama Supreme Court Justice Anthony Dickson Sayre and Minnie Buckner Machen Sayre; as a girl she starred in ballet recitals. **D**
- In July 1918 she met F. Scott Fitzgerald; they married in New York on April 3, 1920, and their only child, Frances "Scottie" Fitzgerald, was born in 1921. **D**
- In the late 1920s she returned to dance. She began ballet lessons at 27 with Lubov Egorova, hoping to dance with the Ballets Russes, and took classes every morning and afternoon, practising for almost eight hours a day. **D**
- In 1930 the stress of her frustrated attempts to become a professional ballerina led to the first of many breakdowns. On a trip to Europe that year she was hospitalized for nervous exhaustion. **D**
- She wrote and painted throughout her life; a 1934 exhibition in New York showed her paintings and drawings. **D**
- Although she was treated for schizophrenia, mental-health experts later contested both the diagnosis and the treatment prescribed by her main physician. **R**
- A psychiatrist writing to the Princeton Alumni Weekly argued that her history of remissions and exacerbations makes schizophrenia highly unlikely and bipolar illness more likely. **R**
- The psychiatrist Mary Seeman, drawing on biographies, describes her illness as showing specific precipitants, discontinuities in its course, pronounced mood swings, preserved intellect and agency, and flare-ups associated with immune and hormonal changes, as an example of how psychosis can present in women. **R**
- Her ballet training has been described as an obsession bordering on mania. The project roster reads it as an exercise compulsion with an eating disorder, an interpretation that no fetched clinical source makes. **R**

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: White cells: 6.1 10*3/uL; Hemoglobin: 12.6 g/dL; Platelets: 248 10*3/uL; Sodium: 139 mmol/L; Potassium: 4 mmol/L; Creatinine: 0.72 mg/dL; eGFR: 116 mL/min/1.73 m²; Glucose: 84 mg/dL; Calcium: 9.4 mg/dL; TSH: 2.1 mIU/L; Prolactin: 62 ng/mL (high); Hemoglobin A1c: 5%; Total cholesterol: 168 mg/dL; LDL cholesterol: 90 mg/dL; HDL cholesterol: 64 mg/dL; Triglycerides: 70 mg/dL; PHQ-9: 11; AUDIT-C: 2. All results are synthetic.

BP 108/68 mmHg; pulse 78 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 50.8 kg; BMI 18.7 kg/m². All vital signs are synthetic.

## Current medications

- Risperidone 2 mg oral tablet, one tablet by mouth at bedtime (started in hospital) **S**

## Plan so far

- Continue the antipsychotic started in hospital, with monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose or A1c and lipids at baseline, 12 weeks and yearly, prolactin because her periods have stopped, side-effect checks, and the AIMS at baseline and every six months. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Consensus development conference on antipsychotic drugs and obesity and diabetes (2004); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Reproductive health on psychiatric medicines: a pregnancy test before any new medicine, valproate avoided because of its risks in pregnancy, counseling on the risks of any mood stabilizer in pregnancy, contraception that suits her, folic acid, and planning with psychiatry before any pregnancy. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024) **S**
- Eating and exercise: the SCOFF screen, menstrual and energy review at each visit, a sports dietitian, and a graded return to dance with food matched to the training load; training hours watched as an early warning sign. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020) **S**
- Coordinated specialty care: a care coordinator, individual therapy with psychoeducation about mood and psychosis, education for the people she chooses, support to return to dance and writing, and a peer specialist. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026) **S**
- Sleep and early warning signs: regular sleep and wake times, no all-night writing or training, and a plan to call the team after two short nights or if training hours climb. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018) **S**
- Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, the PHQ-9 at each visit, and safety review at every visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
